<DOC>
	<DOCNO>NCT00379275</DOCNO>
	<brief_summary>This study evaluate patient sarcoidosis understand disease affect body . Sarcoidosis disease result inflammation body tissue . The lung , lymph node chest , skin eye commonly affect . As disease progress , small lump , granuloma , appear affected tissue . In case , granuloma clear , case heal disappear , tissue tend remain inflamed . Eye inflammation ( uveitis ) associate sarcoidosis cause various eye disease , sometimes lead blindness . This study examine clinical , immunological genetic feature ocular sarcoidosis . Patients 6 year age old sarcoidosis may eligible study . Candidates screen follow procedure : - Completion questionnaire medical , social demographic information - Blood draw laboratory test - Complete eye examination , include measurement eye pressure dilation pupils examine back eye . Fluorescein angiography may do . This test involve inject dye vein arm . The dye travel blood vessel eye . A camera flash blue light eye take picture retina show whether dye leak blood vessel retina . Other photographs eye may also take use special camera . Participants follow conjunction local eye doctor require status disease . Patients whose disease stable see initial examination follow every 12 month 3 year .</brief_summary>
	<brief_title>Eye Immunogenetic Features Sarcoidosis</brief_title>
	<detailed_description>BACKGROUND Sarcoidosis multi-systemic granulomatous disease . The lung , thoracic lymph node , skin eye commonly affect organ . Most patient sarcoidosis present respiratory symptom . Sarcoid uveitis usually suspect ocular inflammation find conjunction suggestive serological radiological study . Currently , diagnosis sarcoidosis require demonstration non-caseating granuloma biopsy ; even always diagnostic ; sensitive specific noninvasive tool need . Ophthalmic involvement report many 40 % patient sarcoidosis , series report ophthalmic finding approximately 25 % patient develop chronic , systemic sarcoidosis . Uveitis associate sarcoidosis diverse , include : acute non-granulomatous chronic granulomatous iridocyclitis , vitritis , retinal vasculitis , choroiditis choroidal granuloma papillitis secondary optic nerve granuloma ; cause ocular morbidity due high incidence glaucoma cataract . Other ophthalmic finding include lacrimal gland enlargement , secondary Sjogren 's disease , scleritis , orbital gland involvement , secondary proliferative retinopathy , subretinal neovascularization , optic neuropathy . To well evaluate diagnose patient , also need improve ability predict susceptibility prognosis , especially among African-Americans . Current epidemiologic study sarcoidosis indicate United States , African Americans threefold high age-adjusted annual incidence , 35.5/100,000 , compare Caucasians , 10.9/100,000 . In addition , African Americans chronic sarcoidosis likely develop ocular manifestation white . The study ocular sarcoidosis important lead inflammatory cause blindness ocular morbidity . In large survey patient uveitis , approximately 5 % patient find ocular sarcoidosis , approximately 10 % patient become blind least one eye . AIMS : AIM 1 : CLINICAL ANALYSIS : Documentation : 1 . Clinical feature sarcoidosis associate uveitis 2 . Chronological association ocular disease histopathologic diagnosis sarcoidos 3 . Family history sarcoidosis 4 . Previous therapy response 5 . Ocular status compare systemic disease status , current historical Environmental exposure history AIM 2 : IMMUNOLOGICAL ANALYSIS : One goal study determine diagnostically important cytokine biopsy-proven ocular sarcoidosis . The chemokine profile Peripheral Blood Mononuclear Cells Broncho-Alveolar Lavage Fluid ( BALF ) pulmonary sarcoidosis patient report many cytokine implicate pathogenesis disease . 1 . Serum Level A. TNF alpha B. MIP-1 alpha C. IL-8 D. IL-2 E. TGF Beta F. INF gamma 2 . Immunophenotyping whole blood cell BALF flow cytometry Focus : A. T cell sub-typing ( example : CD4 , CD8 ) B. NK cell sub-typing ( example : CD56 , KIR ) 3 . TLRs sub-typing AIM 3 : GENETIC ANALYSIS : Serum analysis HLA Class I II type A cohort 100 patient biopsy-proven sarcoidosis recruit Uveitis Ocular Immunology Clinic National Eye Institute Pulmonary Clinic National Heart Lung Blood Institute . FUTURE AIMS : We aim characterize TLR activation profile patient ocular sarcoidosis , compare patient pulmonary sarcoidosis normal volunteer . Using immuno-genetic classification scheme , conjunction HLA typing , hope develop novel diagnostic and/or prognostic criterion sarcoidosis . In addition , TLR activation profile may allow risk stratification different sarcoidosis phenotype . METHODS : A cohort 100 patient biopsy-proven sarcoidosis recruit Uveitis Ocular Immunology Clinic National Eye Institute Pulmonary Clinic National Heart Lung Blood Institute . After obtain informed consent , patient invite participate study . After appropriate enrollment , undergo follow 1 . Completion questionnaire , medical , social demographic data 2 . A complete ophthalmologic examination 3 . Baseline serologic analysis 4 . Baseline serum analysis immunologic analysis 5 . HLA-Typing 6 . Patients quiescent see baseline second visit 1 year 7 . Patients active treat appropriately , refer ophthalmologist treatment protocol National Eye Institute</detailed_description>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Sarcoidosis</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Participants must least 6 year old 2 . Participants must biopsyproven sarcoidosis 3 . Participant must able consent participate protocol 4 . For minor , consent adult necessary EXCLUSION CRITERIA : We exclude participant unable unwilling give blood designate time protocol</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 10, 2007</verification_date>
	<keyword>Sarcoidosis</keyword>
	<keyword>Uveitis</keyword>
	<keyword>Pulmonary Sarcoidosis</keyword>
	<keyword>HLA-Typing</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Serum Markers</keyword>
</DOC>